NCT04978298View on ClinicalTrials.gov

Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

July 19, 2021

Primary Completion Date

February 26, 2023

Study Completion Date

February 26, 2023

Conditions
Healthy Volunteers
Interventions
OTHER

Placebo

Placebo

DRUG

Rasigiline

Rasigiline

DRUG

Phenelzine

Phenelzine

DRUG

Ozanimod

Ozanimod

Trial Locations (1)

92801

Local Institution - 001, Anaheim

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY

NCT04978298 - Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants | Biotech Hunter | Biotech Hunter